1Brewster DC,Cronenwett JL,Hallett JW Jr,et al.Guidelines for the treatment of abdominal aortic aneurysms.Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery[J].J Vasc Surg,2003,37(5):1106-1117.
2Cleeman JI.Executive summary of the thrid report of the national cholesterol education program(NCEP) expert panel on detection,evaluation,and treatment of high blood cholesterol in adult(adult treatment panel Ⅲ) [J].JAMA,2001,285:2486-2497
3Nagashima H,Aoka Y,Sakomura Y,et al.A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor,cerivastatin,suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall[J].J Vasc Surg,2002,36(1):158-163.
5Liao S,Miralles M,Kelley BJ,et al.Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors[J].J Vasc Surg,2001,33:1057-1064.
6Daugherty A,Manning MW,Cassis LA.Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis[J].Br J Pharmacol,2001,134(4):865-870.
8Gadowski GR,Pilcher DB,Ricci MA.Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade[J].J Vasc Surg,1994,19(4):727-731.
9Brophy C,Tilson JE,Tilson MD.Propranolol delays the formation of aneurysms in the male blothy mouse[J].J Surg Res,1988.44:687.
10Propanolol Aneurysm Trial Investigators .Propranolol for small abdominal aortic aneurysms: results of a randomized trial.J Vasc Surg,2002,35(1):72-79.
